Cephalomannine
Cephalomannine is a taxol derivative with antitumor, antiproliferative properties, it shows cytotoxicity in human glial and neuroblastoma cell-lines.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Br J Pharmacol.2016, 173(2):396-410
Plants (Basel).2020, 9(11):1555.
Oxid Med Cell Longev.2022, 2022:9139338.
Industrial Food Engineering2015, 19(4):408-413
Molecules.2019, 24(17):E3127
JLiquid Chromatography & Related Tech.2021, 10826076.
Plants (Basel).2021, 10(2):278.
Biomed Chromatogr.2016, 30(10):1573-81
Nutrients.2021, 13(3):978.
Molecules.2018, 23(7):E1659
Related and Featured Products
Int J Oncol. 1993 Feb;2(2):297-9.
Cephalomannine and 10-deacetyltaxol cytotoxicity in human glial and neuroblastoma cell-lines.[Pubmed:
21573554]
METHODS AND RESULTS:
The cytotoxic effects of taxol, 10-deacetyltaxol, and Cephalomannine at concentrations of 0.1 mug/ml to 10.0 mug/ml for one and 24 hours exposure were determined in two human glioblastoma multiforme and two neuroblastoma cell lines using the MTT method. The neuroblastoma cell lines were established from previously treated patients, while the glioblastomas were from untreated patients. There was a proportionate concentration-toxicity relationship for all four cell lines. The neuroblastoma SK-N-FI was consistently the most resistant to all three drugs. The order of potency after a one hour exposure was taxol, 10-deacetyltaxol and Cephalomannine. Cephalomannine contained 1.5% taxol impurity and 10-deacetyltaxol, 4.5% taxol hence the contribution of taxol to these substances' toxic effects was minimal.
CONCLUSIONS:
We conclude that tumors of the central and peripheral nervous system are sensitive to 10-deacetyltaxol and Cephalomannine and these drugs are less toxic than taxol but remain within a therapeutic range.
Fitoterapia. 2013 Oct;90:79-84.
Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine.[Pubmed:
23876369]
Four paclitaxel derivatives were afforded by preparative HPLC separation of two pairs of diastereoisomers, which were obtained by catalytic hydrogenation and epoxidation of the C-13 side-chain double bond of Cephalomannine, a naturally occurring paclitaxel analog.
METHODS AND RESULTS:
The four paclitaxel derivatives were analyzed using NMR, CD spectroscopy, and side-chain hydrolysis in order to measure their optical rotations and GC characteristics. In this way, the stereoconfigurations of the products were determined. Evaluation of the compounds' activity indicated that they had differing cytotoxic activities: compound 5 had superior activity in BCG-823 tumor cells compared to paclitaxel, while compound 7 had superior activity in HCT-8 and A549 tumor cells compared to paclitaxel.
CONCLUSIONS:
These results indicate that the stereoconfiguration of the paclitaxel N-acyl side chain has a significant impact on its activity.
Drug Metab Dispos. 2008 Feb;36(2):418-26.
Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.[Pubmed:
18039807]
To investigate how taxane's substituents at C3' affect its metabolism, we compared the metabolism of Cephalomannine and paclitaxel, a pair of analogs that differ slightly at the C3' position.
METHODS AND RESULTS:
After Cephalomannine was incubated with human liver microsomes in an NADPH-generating system, two monohydroxylated metabolites (M1 and M2) were detected by liquid chromatography/tandem mass spectrometry. C4'' (M1) and C6alpha (M2) were proposed as the possible hydroxylation sites, and the structure of M1 was confirmed by (1)H NMR. Chemical inhibition studies and assays with recombinant human cytochromes P450 (P450s) indicated that 4''-hydroxyCephalomannine was generated predominantly by CYP3A4 and 6alpha-hydroxyCephalomannine by CYP2C8. The overall biotransformation rate between paclitaxel and Cephalomannine differed slightly (184 vs. 145 pmol/min/mg), but the average ratio of metabolites hydroxylated at the C13 side chain to C6alpha for paclitaxel and Cephalomannine varied significantly (15:85 vs. 64:36) in five human liver samples. Compared with paclitaxel, the major hydroxylation site transferred from C6alpha to C4'', and the main metabolizing P450 changed from CYP2C8 to CYP3A4 for Cephalomannine. In the incubation system with rat or minipig liver microsomes, only 4''-hydroxyCephalomannine was detected, and its formation was inhibited by CYP3A inhibitors. Molecular docking by AutoDock suggested that Cephalomannine adopted an orientation in favor of 4''-hydroxylation, whereas paclitaxel adopted an orientation favoring 3'-p-hydroxylation. Kinetic studies showed that CYP3A4 catalyzed Cephalomannine more efficiently than paclitaxel due to an increased V(m).
CONCLUSIONS:
Our results demonstrate that relatively minor modification of taxane at C3' has major consequence on the metabolism.
